After a career with Médecins Sans Frontières, MA got involved in cancer research. MA coordinated the evaluation of new screening methods in the framework of the European Network of Cervical Cancer Screening and is editor-in-chief of the 2nd edition of the European Guidelines for Cervical Cancer Screening and associated Supplements on HPV screening. His main activity deals with systematic reviews and meta-analyses regarding prevention and treatment of HPV-related (pre-)cancers. MA is involved in several international networks dealing with biobank-based cancer research, clinical validation of tests applied in screening, diagnosis and prognosis prediction, evaluation of HPV vaccines and offers epidemiological support to health authorities regarding implementation of cervical cancer prevention worldwide.
MA is author of >400 peer-reviewed papers related to cancer prevention. MA is principle investigator of the VALGENT and VALHUDES studies. These are independent researcher-induced protocols used for HPV test comparison and validation on clinician-collected cervical samples, vaginal self-samples and urine. MA is currently updating methods for test validation in collaboration with a multi-disciplinary international network of experts.
MA is also conducting an individual-patient-data meta-analysis regarding attendance to cervical cancer screening subsequent to the offer of self-sampling kits.
Publications list:https://scholar.google.com/citations?user=zmnuDcQAAAAJ&hl=nl&oi=ao
h-index: 106. >60,000.citations.
